NCT06773546View on ClinicalTrials.gov

Immunodysregulation As an Expression of Underlying Inborn Errors of Immunity: Implementation of Diagnostics and Management of Pediatric and Adult Patients with Immune System Disorders

RecruitingOBSERVATIONAL

Enrollment

400

Participants

Timeline

Start Date

September 15, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions

Inborn Errors of Immunity

Trial Locations (1)

40138

RECRUITING

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna

All Listed Sponsors

lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

NCT06773546 - Immunodysregulation As an Expression of Underlying Inborn Errors of Immunity: Implementation of Diagnostics and Management of Pediatric and Adult Patients with Immune System Disorders | Biotech Hunter | Biotech Hunter